PPTMF (Perpetua Medical AB) GF Score: 57/100 (As of Jun. 29, 2026) — 10% Above Median


PPTMF Perpetua Medical AB PPTMF
57 GF Score
Price $1.08
GF Value $1.15
! 6 Warning Signs
View Full Analysis

What is Perpetua Medical AB GF Score?

Perpetua Medical AB PPTMF 57 GF Score is 57 as of Jun. 29, 2026, which is 10% above its 10-year median of 52.00. GuruFocus rates PPTMF with a GF Score™ of 57/100 and a GF Value™ of $1.15. The stock has 6 warning signs investors should review.

Perpetua Medical AB has the GF Score of 57, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 6/10
2. Profitability Rank : 2/10
3. Growth Rank : 1/10
4. GF Value Rank : 7/10
5. Momentum Rank : 7/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Perpetua Medical AB might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Perpetua Medical AB  (OTCPK:PPTMF) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Perpetua Medical AB GF Score Related Terms

PPTMF vs ABT, SYK, MDT: GF Score Comparison

For the Medical Devices subindustry, Perpetua Medical AB's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perpetua Medical AB GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perpetua Medical AB's GF Score distribution charts can be found below:

* The bar in red indicates where Perpetua Medical AB's GF Score falls into.


PPTMF
57GF Score
Perpetua Medical AB PPTMF
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 57 mean?
Perpetua Medical AB (PPTMF) has a GF Score of 57 as of Jun. 29, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Perpetua Medical AB and its competitors. This is 10% above median its historical median of 52.00. Over the past decade, Perpetua Medical AB's GF Score has ranged from 15.00 to 67.00.
Is Perpetua Medical AB's GF Score too high?
Perpetua Medical AB's current GF Score of 57 is 10% above median its 10-year median of 52.00. Over the past 10 years, this metric has ranged from a low of 15.00 to a high of 67.00. Overall, Perpetua Medical AB has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Perpetua Medical AB's GF Score compare to ABT and SYK?
Perpetua Medical AB's GF Score of 57 can be compared against companies in the Medical Devices & Instruments industry. Historically, Perpetua Medical AB's own GF Score has ranged from 15.00 to 67.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Perpetua Medical AB and its competitors. Perpetua Medical AB's current GF Score is 57, which is 10% above median its own 10-year median of 52.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perpetua Medical AB stock overvalued right now?
Perpetua Medical AB (PPTMF) has a current GF Score of 57. The stock's GF Value™ is $1.15, compared to a current price of $1.08 — trading 6.2% below its estimated fair value. The current GF Score is 57, which is 10% above median its 10-year median of 52.00. Perpetua Medical AB's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Perpetua Medical AB (PPTMF), the current GF Score is 57 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perpetua Medical AB (PPTMF) Overvalued in 2026?

Based on GuruFocus' analysis, Perpetua Medical AB stock appears to be undervalued. The current stock price of $1.08 is trading 6.2% below its estimated GF Value™ of $1.15.

Key valuation signals for PPTMF:

  • GF Score: 57 (10% above median its 10-year median of 52.00)
  • GF Value™: $1.15 vs. price of $1.08 (6.2% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the PPTMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perpetua Medical AB Business Description

Other Exchanges PERP B:Sweden
Address Ekeby Bruk 2H, Uppsala, SWE, SE-752 63
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
57GF Score

Get the complete analysis for PPTMF

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.08
Price
$1.15
GF Value